Modulation of G Proetin Signaling Normalizes Tumor Vessels

Mitali Manzur, Juliana Hamzah, Ruth Ganss

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)


G protein–coupled biological processes are important for an ever-increasing number of human diseases and require fine-tuning through accessory molecules such as the regulators of G protein signaling (RGS). RGS5, a marker for tumor-resident pericytes, was recently established as playing a pivotal role in vascular maturation and vessel remodeling during carcinogenesis. Remarkably, tumors arising in a RGS5-deficient background display vessels with normalized morphology and an overall improved blood flow. Furthermore, these morphologic changes also lead to dramatic improvements in lymphocyte access to tumors and success of antitumor immunotherapy. Here, we consider the implications of these findings, and how they contribute to enhancing our understanding of remodeling angiogenic vessels as means for improving anticancer therapies. [Cancer Res 2009;69(2):396–9]
Original languageEnglish
Pages (from-to)396-399
JournalCancer Research
Issue number2
Publication statusPublished - 2009


Dive into the research topics of 'Modulation of G Proetin Signaling Normalizes Tumor Vessels'. Together they form a unique fingerprint.

Cite this